Page last updated: 2024-11-13

chondramide a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chondramide A: from Chondromyces crocatus and Toxoplasma gondii; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

chondramide A : A chondramide that is chondramide C in which the pro-S hydrogen at position 2 of the beta-tyrosine residue is replaced by a methoxy group. It is produced by strains of the myxobacterium, Chondromyces crocatus. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID46217451
CHEMBL ID2426319
CHEBI ID84380
MeSH IDM0257093

Synonyms (5)

Synonym
CHEMBL2426319
chebi:84380 ,
(3s,4s,7r,10s,13s,15e,17r,18r)-4-(4-hydroxyphenyl)-7-(1h-indol-3-ylmethyl)-3-methoxy-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadec-15-ene-2,6,9,12-tetrone
chondramide a
Q27157722
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
chondramideAny of the 18-membered ring cyclodepsipeptides produced by strains of the myxobacterium, Chondromyces crocatus.
indolesAny compound containing an indole skeleton.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID771589Induction of Toxoplasma gondii N-terminally his-tagged recombinant actin polymerization at 0.25 uM after 1 hr using phalloidin staining by fluorescence microscopic analysis2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Synthetic chondramide A analogues stabilize filamentous actin and block invasion by Toxoplasma gondii.
AID771590Induction of Toxoplasma gondii N-terminally his-tagged recombinant actin polymerization after 1 hr2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Synthetic chondramide A analogues stabilize filamentous actin and block invasion by Toxoplasma gondii.
AID771591Cytotoxicity against HFF after 72 hrs2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Synthetic chondramide A analogues stabilize filamentous actin and block invasion by Toxoplasma gondii.
AID771592Antiparasitic activity against Toxoplasma gondii expressing beta-galactosidase infected in HFF assessed as parasite growth inhibition after 72 hrs2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Synthetic chondramide A analogues stabilize filamentous actin and block invasion by Toxoplasma gondii.
AID771588Induction of Toxoplasma gondii N-terminally his-tagged recombinant actin polymerization at 2 uM after 1 hr using phalloidin staining by fluorescence microscopic analysis2013Journal of natural products, Sep-27, Volume: 76, Issue:9
Synthetic chondramide A analogues stabilize filamentous actin and block invasion by Toxoplasma gondii.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's3 (23.08)29.6817
2010's8 (61.54)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.18 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]